Jonathan Bliggenstorfer to Rectal Neoplasms
This is a "connection" page, showing publications Jonathan Bliggenstorfer has written about Rectal Neoplasms.
Connection Strength
3.216
-
Bliggenstorfer JT, Hashmi A, Bingmer K, Chang C, Liu JC, Ginesi M, Stein SL, Steinhagen E. Sarcopenia in Patients With Rectal Adenocarcinoma: An Opportunity for Preoperative Rehabilitation. Am Surg. 2023 Dec; 89(12):5631-5637.
Score: 0.721
-
Bliggenstorfer JT, Ginesi M, Steinhagen E, Stein SL. Lymph node yield after rectal resection is a predictor of survival among patients with node-negative rectal adenocarcinoma. Surgery. 2022 Nov; 172(5):1292-1299.
Score: 0.672
-
Bliggenstorfer JT, Ofshteyn A, Bingmer K, Ginesi M, Steinhagen E, Stein SL. Predictors of curative-intent oncologic management among patients with stage IV rectal cancer. Am J Surg. 2022 04; 223(4):738-743.
Score: 0.644
-
Bliggenstorfer JT, Bingmer K, Ofshteyn A, Stein SL, Charles R, Steinhagen E. Neoadjuvant radiation above NCCN guidelines for rectal cancer is associated with age under 50 and early clinical stage. Surg Endosc. 2022 05; 36(5):2925-2935.
Score: 0.639
-
Sawaf T, Gudipudi R, Ofshteyn A, Sarode AL, Bingmer K, Bliggenstorfer J, Stein SL, Steinhagen E. Disparities in Clinical Trial Enrollment and Reporting in Rectal Cancer: A Systematic Review and Demographic Comparison to the National Cancer Database. Am Surg. 2024 Jan; 90(1):130-139.
Score: 0.187
-
Brady JT, Bingmer K, Bliggenstorfer J, Xu Z, Fleming FJ, Remzi FH, Monson JRT, Wexner SD, Dietz DW. Could meeting the standards of the National Accreditation Program for Rectal Cancer in the National Cancer Database improve patient outcomes? Colorectal Dis. 2023 05; 25(5):916-922.
Score: 0.180
-
Chang C, Bliggenstorfer JT, Liu J, Shearer J, Dreher P, Bingmer K, Stein SL, Steinhagen E. Not All Patients With Locally Advanced Rectal Cancer Benefit From Neoadjuvant Therapy. Am Surg. 2023 Nov; 89(11):4327-4333.
Score: 0.172